Regular (statutory) individual vaccinations for children

Routine vaccinations (vaccinations based on the Vaccination Act) are carried out to prevent the occurrence and spread of infectious diseases.

The pediatric pneumococcal vaccine (20-valent) will be included in the routine vaccination schedule. Accordingly, the routine vaccination of the pediatric pneumococcal vaccine (13-valent) will end.
Note: For details on each vaccination, please see below.

The Hib infection and quadrivalent (DPT-IPV) vaccine will be changed to the pentavalent (DPT-IPV-Hib) vaccine. In addition, the childhood pneumococcal vaccination will be changed from 13-valent to 15-valent.
Note: For details on each vaccination, please see below.

The city is currently accepting applications for "Diphtheria, whooping cough, acute Poliomyelitis ( ) The "vaccination against polio, tetanus and Hib infection" is called the "pentavalent vaccination."
Note: If you have already received the quadrivalent vaccine or Hib vaccine, you will continue to receive the quadrivalent vaccine and Hib vaccine. In principle, you cannot switch to the pentavalent vaccine midway through your vaccination, but if you are unable to complete your vaccination with the same vaccine due to the discontinuation of the quadrivalent vaccine, you may be able to switch to the pentavalent vaccine as an "unavoidable circumstance." In that case, please consult with your vaccinating doctor before proceeding with the vaccination.

1st period initial vaccination (1st, 2nd, 3rd)

• Target audience: Children between the ages of 2 months old and 7 years and 6 months old.
• Number of vaccinations: 3 vaccinations at intervals of 20 to 56 days
• Notification period: Before 2 months old

1st stage additional vaccination

• Target audience: Children between the ages of 2 months old and 7 years and 6 months old.
• Number of vaccinations: 1 vaccination between 6 and 18 months after the first vaccination
• Notification period: Before 2 months old

A pre-examination form for the pentavalent vaccine is enclosed with the individual notification (pre-examination form, etc.) sent to those born after February 2024. However, those born before January 2024 who have never received the quadrivalent vaccine or Hib vaccine can be vaccinated with the pentavalent vaccine. If you wish to receive the pentavalent vaccine, please bring your maternal and child health handbook to the health center. After checking your vaccination history, we will give you a pre-examination form, etc.

• Target: Children born on or after August 1, 2020
• Number of vaccinations: 2 or 3 times (depending on the type of vaccine)
• Notification period: Before 2 months old

• Target audience: Children between the ages of 2 months and 5 years old
• Number of vaccinations: 4 times (depending on the age at which vaccination starts)
• Notification period: Notifications have been sent to those born before January 2024. For those born after February 2024, notifications have been switched to pre-examination forms for the Pentavalent Virus (DPT-IPV-Hib) vaccine.

From October 1, 2024, the pediatric pneumococcal (20-valent) vaccine will be included in the regular vaccination schedule. As a result, the regular vaccination schedule for the pediatric pneumococcal (13-valent) vaccine will end. From October onwards, the "15-valent" or "20-valent" vaccine will be used.
Those who are currently receiving the 13-valent vaccine or who are about to start receiving the vaccine will generally be receiving the 20-valent vaccine.
Note: For information on alternate vaccinations, see below.

• Target audience: Children between the ages of 2 months and 5 years old
• Number of vaccinations: 4 times (depending on the age at which vaccination starts)
• Notification period: Before 2 months old

For those who have started vaccination with the 13-valent vaccine, please switch to the 20-valent vaccine and proceed with vaccination.
If you have switched from the 13-valent to the 15-valent vaccine and are currently undergoing vaccination, please continue with the 15-valent vaccine.
Note: The safety and effectiveness of switching from the "15-valent" to the "20-valent" vaccine has not been established.

• Eligible persons: Children under 1 year old
• Number of vaccinations: 3 times
• Notification period: Before 2 months old

The city is currently accepting applications for "Diphtheria, whooping cough, acute Poliomyelitis ( ) The "four-in-one vaccination" is called the "four-in-one vaccination."

1st period initial vaccination (1st, 2nd, 3rd)

• Target audience: Children between the ages of 2 months old and 7 years and 6 months old.
• Number of vaccinations: 3 vaccinations at intervals of 20 to 56 days
• Notification period: Notifications have been sent to those born before January 2024. For those born after February 2024, notifications have been switched to pre-examination forms for the Pentavalent Virus (DPT-IPV-Hib) vaccine.

1st stage additional vaccination

• Target audience: Children between the ages of 2 months old and 7 years and 6 months old.
• Number of vaccinations: 1 vaccination between 12 and 18 months after the first vaccination
• Notification period: Notifications have been sent to those born before January 2024. For those born after February 2024, notifications have been switched to pre-examination forms for the Pentavalent Influenza Pneumonia (DPT-IPV-Hib) vaccine.

1st term

• Eligible participants: Children between 1 and 2 years old
• Notification period: Before the child turns 1 year old

2nd term

• Eligible persons: Children aged 5 to 7 who have not yet entered elementary school (children born between April 2, 2018 and April 1, 2019)
• Notification period: Early April

• Target audience: Children between the ages of 1 and 3 years old
• Notification period: Before the child turns 1 year old
• Number of vaccinations: 2

standard inoculation

First period (1st and 2nd)

• Target children: Children between the ages of 6 months and 7 years and 6 months (standard vaccination age: from 3 years old to 4th birthday)
• Number of vaccinations: 2 vaccinations at intervals of 6 to 28 days
• Notification period: Before turning 3 years old

1st season added

• Target audience: Children between the ages of 6 months and 7 years and 6 months.
• Number of vaccinations: 1 vaccination approximately 1 year after the completion of the 2nd vaccination in the first period
• Notification period: Before turning 4 years old

2nd term

• Eligible participants: Children aged 9 to 13 years old
• Number of vaccinations: 1 vaccination
• Notification period: Month when the child turns 9 years old

Vaccination under special measures

The Vaccination Enforcement Order and Vaccination Implementation Regulations were amended on May 20, 2011, and the legal vaccination age was expanded as follows to include those who missed the opportunity to be vaccinated due to the suspension of vaccination recommendations.
(1) Those born between June 1, 1995 and April 1, 2007, and who are under the age of 20.
Note: As of April 1, 2013, people born between April 1, 1995 and May 31, 1995 are now eligible to receive the vaccine.
(2) has now ended.
(2) Those born between April 2, 2007 and October 1, 2009, who have not completed the first round of Japanese encephalitis vaccination by March 31, 2010, and who are between 6 and 90 months of age, or 9 years or older but under 13 years of age.

Note : Pre-examination slips will be given to you at each medical institution or health center. Please be sure to bring your maternal and child health handbook with you when you come.
For more information about Japanese encephalitis, please see About Japanese Encephalitis Vaccination .

• Target audience: Children aged 11 to under 13
• Number of vaccinations: 1 vaccination
• Notification period: Before turning 11 years old

From April 1, 2020, human papillomavirus infection vaccination will be actively recommended. Please check this out for details.

• Target: Girls from 6th grade to 1st year of high school
• Number of vaccinations: 3 or 2 doses Note: For the 9-valent HPV vaccine only, if the first dose is received before the child turns 15 years old, it is possible to complete the vaccination with 2 doses.　
• Notification period: The awards will be sent to girls in the first year of junior high school during April 2024.

Note: For those born between April 2, 1997 and April 1, 2008 , even if they are over the eligible age, they can receive the vaccine at public expense until the end of March 2025 as a catch-up vaccination.

Vaccination dates, times, vaccine availability, etc. vary by each medical institution, so please see the list of medical institutions below and call ahead to confirm.
Note: Due to an agreement between the five Minamitama Health and Medical Area cities, vaccinations can also be administered at medical institutions in Hachioji, Machida, Hino, and Tama cities. For more information, please see Routine Vaccinations for Children (when receiving at medical institutions in Hachioji, Machida, Hino, and Tama City) . If you wish to receive vaccinations at other medical institutions due to reasons such as returning home to give birth, please contact the Health Center as you will need to apply in advance.

As a treatment for a disease, the patient has lost immunity due to a special reason such as undergoing bone marrow transplant surgery, and the doctor has determined that the effectiveness of the routine vaccinations that have already been given cannot be expected, and that revaccination can be expected to provide immunity. We will subsidize the cost of the vaccination if you voluntarily receive the relevant vaccination again.

Advance application is required. For details, please contact the Health Center.

If a side effect caused by a routine vaccination causes health damage, such as requiring treatment at a medical institution or interfering with daily life, you will receive benefits based on the Immunization Act. can do.
Depending on the degree of health damage, there are three categories: medical expenses, medical allowance, disability pension, disability pension, lump-sum death benefit, and funeral expenses, and the amount stipulated by law will be paid.
However, the causal relationship between the health damage caused by the vaccination or another factor (infectious disease introduced before or after vaccination, or another cause, etc.) must be determined by vaccination, infectious disease treatment, etc. This will be deliberated by a national examination committee consisting of experts in various fields such as law, and if it is determined that the cause is due to vaccination, you will be able to receive benefits.
If you need to apply for benefits, please contact the doctor who examined you or the Inagi City Health Department.

Reference: Please see the Ministry of Health, Labor and Welfare's " Vaccination Health Damage Relief System (External link)."